Omclidinium inhalation powder (Anoro Ellipta)
This combined anticholinergic and beta-adrenergic agonist (LABA) drug is used to remove long-term obstruction in the airways and relieve symptoms of chronic obstructive pulmonary disease (COPD) and improve airflow in patients with chronic bronchitis and/or emphysema. Omclidinium drug is not used to treat sudden shortness of breath and improve bronchospasm attacks in asthma attacks. This medicine is taken once a day. Anoro spray is one of the so-called DPI drugs and it enters the lungs by suction or inhalation of the drug (in the form of powder) and not as a puff. The dose and amount of Omclidinium varies from person to person. This medicine should be kept in a dry and cool place away from heat and direct sunlight. Throw away the spray 6 weeks after opening or when the dose indicator reads zero (whichever comes first). Omclidinium drug is not approved for use by people under 18 years of age.
Absorption: Systemic, primarily through the lungs
Time Plasma peak: 5 to 15 minutes Metabolism: Liver
Disposal: Urine and feces
Half Life: 11 hours
Contraindications to Omclidinium medicine
- Allergy to this drug or other drugs and food such as milk protein sensitivity
- Pregnancy or intention to become pregnant and breastfeeding
- Cardiovascular problems or irregular heartbeat
- Eye disease called glaucoma
- Prostate problems or urination
